keyword
https://read.qxmd.com/read/38655516/cannabis-use-and-mood-disorders-a-systematic-review
#1
JOURNAL ARTICLE
Maryam Sorkhou, Eliza L Dent, Tony P George
BACKGROUND: Problematic cannabis use is highly prevalent among people with mood disorders. This underscores the need to understand the effects of cannabis and cannabinoids in this population, especially considering legalization of recreational cannabis use. OBJECTIVES: We aimed to (1) systematically evaluate cross-sectional and longitudinal studies investigating the interplay between cannabis use, cannabis use disorder (CUD), and the occurrence of mood disorders and symptoms, with a focus on major depressive disorder (MDD) and bipolar disorder (BD) and; (2) examine the effects of cannabis on the prognosis and treatment outcomes of MDD and BD...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38653851/analyzing-the-quality-of-life-in-individuals-with-fragile-x-syndrome-in-relation-to-sleep-and-mental-health
#2
JOURNAL ARTICLE
Amrita Minhas, Kerri Whitlock, Cory Rosenfelt, Julie Shatto, Brittany Finlay, Jennifer Zwicker, Sarah Lippe, Sebastien Jacquemont, Randi Hagerman, Kara Murias, Francois V Bolduc
The purpose of this paper was to examine the physical, emotional, social and school functioning domains of quality of life of individuals with Fragile X Syndrome, in relation to mental health and sleep patterns to gain a better understanding of how these aspects are affected by the disorder. This study included 119 individuals with Fragile X Syndrome who were given different cognitive examinations by a neuropsychologist or by parent-proxy questionnaires. This study focused on the Pediatric Quality of Life Inventory (PedsQoL), the Anxiety, Depression and Mood Scale (ADAMS), the Children's Sleep Habits Questionnaire (CSHQ), but did include other cognitive tests (Vineland Adaptive Behaviour Scales, Nonverbal IQ, Autism Diagnostic Observation Schedule)...
April 23, 2024: Journal of Autism and Developmental Disorders
https://read.qxmd.com/read/38653574/study-of-the-different-sleep-disturbances-during-the-prodromal-phase-of-depression-and-mania-in-bipolar-disorders
#3
JOURNAL ARTICLE
Louise Basquin, Julia Maruani, Jeanne Leseur, Sibylle Mauries, Balthazar Bazin, Guillaume Pineau, Chantal Henry, Michel Lejoyeux, Pierre A Geoffroy
BACKGROUND: One of the challenges in bipolar disorder (BD) lies in early detection of the illness and its recurrences, to improve prognosis. Sleep disturbances (SD) have been proposed as reliable predictive markers of conversion. While preliminary studies have explored the relationship between SD and the onset of mood episodes, the results remain heterogeneous and a few have specifically examined patients' perception of prodromal symptoms and their progression until the episode occurs...
April 23, 2024: Bipolar Disorders
https://read.qxmd.com/read/38652144/-max-reger-and-his-early-death-could-it-have-been-avoided-would-he-have-lived-longer-with-adequate-intensive-care
#4
JOURNAL ARTICLE
Hans-Joachim Trappe
BACKGROUND: Max Reger was an organist, university teacher and composer whose life, illnesses, death and dying are not or hardly known to many. OBJECTIVES: Which illnesses determined Reger's life and did his lifestyle and illnesses influence his compositional work? Could his early death have been avoided? From today's point of view, could modern intensive care medicine have helped him? MATERIAL AND METHODS: A detailed analysis of Reger's diseases was performed using scientific databases (medline, pubmed)...
April 23, 2024: Medizinische Klinik, Intensivmedizin und Notfallmedizin
https://read.qxmd.com/read/38651009/significant-improvements-in-the-olfactory-sensitivity-of-bipolar-i-disorder-patients-during-euthymia-versus-manic-episodes-a-longitudinal-study
#5
JOURNAL ARTICLE
Xianlin Liu, Langjun Su, Yingying Li, Huiqian Yuan, Ao Zhao, Chunhong Yang, Chao Chen, Chunyang Li
INTRODUCTION: Research has indicated that individuals diagnosed with bipolar disorder (BD) might experience alterations in their olfaction or levels of serum tumor necrosis factor-α (TNF-α), but no studies have investigated olfactory function and serum TNF-α in BD patients simultaneously. Moreover, there is a lack of existing research that compares the longitudinal olfactory function between individuals with manic and euthymic BD I. METHODS: Patients with manic BD I (BDM, n=44) and healthy controls (HCs, n=32) were evaluated symptoms (measured via the Young Manic Rating Scale, YRMS), social function (measured via the Global Assessment Function, GAF), serum TNF-α, and olfactory function (via the Sniffin' Sticks test) including olfactory sensitivity (OS) and olfactory identification (OI)...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38650515/-multiple-sclerosis-and-bipolar-disorder-an%C3%A2-overlap-between-soma-and-psyche
#6
JOURNAL ARTICLE
K N Rennert, T J Verduijn, D G H Krol
This clinical vignette describes a 29-year-old woman who had her first neurological manifestations of multiple sclerosis (MS) on the same day as a second lifetime manic episode as part of a bipolar I disorder. The patient was stable for eight years before this episode. An MRI-scan conducted during admission showed multiple demyelinating lesions in the frontal cortex, which might have influenced the development and course of the manic episode. Her manic symptoms went into remission during the same time as her neurological symptoms...
2024: Tijdschrift Voor Psychiatrie
https://read.qxmd.com/read/38646846/manic-episode-associated-with-baclofen-use-a-case-report
#7
JOURNAL ARTICLE
Merve Akkuş
No abstract text is available yet for this article.
April 22, 2024: Bipolar Disorders
https://read.qxmd.com/read/38641892/study-on-exosomes-for-identifying-bipolar-disorder-in-early-stage-a-cross-sectional-and-validation-study-protocol
#8
JOURNAL ARTICLE
Yanqing Wu, Yuchao Li, Xuguang An, Jiangong Li, Chenghao Yang, Yi Wang
BACKGROUND: The difficulty is remained to accurately distinguish bipolar disorder (BD) from major depressive disorder (MDD) in early stage, with a delayed diagnosis for 5-10 years. BD patients are often treated with antidepressants systematically due to being diagnosed with MDD, affecting the disease course and clinical outcomes. The current study aims to explore the role of plasma exosomes as biomarker to distinguish BD from MDD in early stage. METHODS: Two stages are included...
April 2024: Brain and Behavior
https://read.qxmd.com/read/38639725/early-warning-signals-observed-in-motor-activity-preceding-mood-state-change-in-bipolar-disorder
#9
JOURNAL ARTICLE
Petter Jakobsen, Ulysse Côté-Allard, Michael Alexander Riegler, Lena Antonsen Stabell, Andrea Stautland, Tine Nordgreen, Jim Torresen, Ole Bernt Fasmer, Ketil Joachim Oedegaard
INTRODUCTION: Alterations in motor activity are well-established symptoms of bipolar disorder, and time series of motor activity can be considered complex dynamical systems. In such systems, early warning signals (EWS) occur in a critical transition period preceding a sudden shift (tipping point) in the system. EWS are statistical observations occurring due to a system's declining ability to maintain homeostasis when approaching a tipping point. The aim was to identify critical transition periods preceding bipolar mood state changes...
April 19, 2024: Bipolar Disorders
https://read.qxmd.com/read/38635860/vitamin-d3-and-zinc-supplements-augment-the-antimanic-efficacy-of-lithium-and-olanzapine-treatments-in-an-animal-model-of-mania
#10
JOURNAL ARTICLE
Aya A S Huzayyin, Michael K Ibrahim, Nahed M A Hassanein, Helmy M S Ahmed
Objective: Bipolar disorder (BD) is a challenging psychiatric disorder and a complex disease. The associated reduction in serum vitamin D3 (VitD3 ) levels in BD patients and the contribution of zinc (Zn) to the treatment, along with the severe side effects of lithium (Li) treatment, were encouraging to assess the efficacy of different correlated combinations of therapeutic/nutraceutical treatments such as olanzapine (Oln), VitD3, and Zn against Li. Methods: Mania was induced in C57BL/6 mice by administering methylphenidate (MPH) for 14 consecutive days...
April 18, 2024: Nutritional Neuroscience
https://read.qxmd.com/read/38627086/difference-between-quantitative-electroencephalography-loudness-dependence-of-auditory-evoked-potential-and-mismatch-negativity-between-a-manic-and-a-depressive-episode-in-a-single-bipolar-patient-with-mixed-features
#11
Young-Min Park
This study compares the changes in Quantitative electroencephalography (QEEG), loudness dependence of auditory evoked potentials (LDAEP), and mismatch negativity (MMN) in the case of bipolar depression, mania, and euthymia in a single patient. the characteristic of QEEG in this patient with mixed depression was an increase in alpha; in mixed mania, there was little increase in alpha, and the decrease in delta, theta, and beta was noticeable. LDAEP increased more in the manic phase than in the depressive phase...
May 31, 2024: Clinical Psychopharmacology and Neuroscience: the Official Scientific Journal of the Korean College of Neuropsychopharmacology
https://read.qxmd.com/read/38627069/bipolar-disorder-circadian-rhythm-and-clock-genes
#12
REVIEW
Junsoo Chung, Young-Chan Kim, Jong-Hyun Jeong
Sleep disturbance and abnormal circadian rhythm might be closely related to bipolar disorder. Several studies involving disturbed sleep/wake cycle, changes in rhythms such as melatonin and cortisol, clock genes, and circadian preference have shown the relationship between bipolar disorder and circadian rhythm. The results differed across different studies. In some studies, a delay in the circadian rhythm was observed in the depressive episode and advanced circadian rhythm was observed during the manic episode...
May 31, 2024: Clinical Psychopharmacology and Neuroscience: the Official Scientific Journal of the Korean College of Neuropsychopharmacology
https://read.qxmd.com/read/38622012/study-on-the-correlation-between-hcy-and-hs-crp-levels-and-cognitive-function-in-patients-with-bipolar-disorder-and-borderline-personality-disorder
#13
JOURNAL ARTICLE
Chaomin Wang, Lizhao Lv, Bo Xin, Na Li, Jincheng Wang, Cuixia An, Kun Zhang
OBJECTIVE: This study aims to explore the correlation and clinical significance of homocysteine and high-sensitivity C-reactive protein levels with cognitive function in patients with bipolar disorder (BD) and borderline personality disorder (BPD). METHODS: Patients with BD admitted to our hospital from January 2022 to December 2022 were chosen retrospectively. BPD patients were categorized into comorbidity groups, while those without BPD were assigned to non-comorbidity groups, each consisting of 60 cases...
April 2024: Actas Españolas de Psiquiatría
https://read.qxmd.com/read/38618630/endoxifen-in-treatment-of-individuals-with-borderline-personality-disorder-with-predominant-impulsivity-a-case-series
#14
Debanjan Banerjee, Rajashree Ray
Endoxifen, a protein kinase C inhibitor, has been approved for use in manic episodes in India. One of the symptom traits that it predominantly targets is impulsivity. Impulsivity can also be a symptom dimension of other mental health conditions, one of which is Borderline Personality Disorder (BPD). Management of BPD is challenging, with limited pharmacological options that are symptom-directed and psychotherapy sessions that are fraught with early dropouts and lack of compliance. Impulsive behaviors represent a major reason for seeking help in BPD, especially with regard to non-suicidal self-injury, substance abuse, high-risk sexual behavior, aggression, etc...
December 22, 2023: Consort Psychiatr
https://read.qxmd.com/read/38615177/hemodynamics-and-arrhythmia-disorder-caused-by-lithium-poisoning-a-case-report
#15
JOURNAL ARTICLE
Yujue Wang, Lijun Ouyang, Xiaoqian Ma, Danyan Xu, Xiaogang Chen, Ying He
Bipolar affective disorder refers to a category of mood disorders characterized clinically by the presence of both manic or hypomanic episodes and depressive episodes. Lithium stands out as the primary pharmacological intervention for managing bipolar affective disorder. However, its therapeutic dosage closely approaches toxic levels. Toxic symptoms appear when the blood lithium concentration surpasses 1.4 mmol/L, typically giving rise to gastrointestinal and central nervous system reactions. Cardiac toxicity is rare but serious in cases of lithium poisoning...
January 28, 2024: Zhong Nan da Xue Xue Bao. Yi Xue Ban, Journal of Central South University. Medical Sciences
https://read.qxmd.com/read/38609342/cariprazine-as-a-maintenance-therapy-in-the-prevention-of-mood-episodes-in-adults-with-bipolar-i-disorder
#16
JOURNAL ARTICLE
Roger S McIntyre, Bethany Davis, Jane Rodgers, Ludmyla Rekeda, Julie Adams, Lakshmi N Yatham
INTRODUCTION: Cariprazine treats acute manic and depressive episodes in bipolar I disorder (BP-I), but its efficacy in preventing relapse of mood episode remains unknown. METHODS: In this phase 3b, double-blind, placebo-controlled study, patients with BP-I with acute manic or depressive episodes (each with/without mixed features), were treated with cariprazine 3.0 mg/day during a 16-week open-label treatment period; those who achieved stable remission within 8 weeks and remained stable for at least another 8 weeks were randomized to receive cariprazine 1...
April 12, 2024: Bipolar Disorders
https://read.qxmd.com/read/38604233/association-between-electroconvulsive-therapy-and-time-to-readmission-after-a-manic-episode
#17
JOURNAL ARTICLE
Katarzyna Popiolek, Tor Arnison, Susanne Bejerot, Katja Fall, Mikael Landén, Axel Nordenskjöld
OBJECTIVE: The majority of patients hospitalized for treatment of a manic episode are readmitted within 2 years despite maintenance treatment. Electroconvulsive therapy (ECT) has been associated with lower rehospitalization rates in some psychiatric conditions, but its association with readmission after a manic episode has not been investigated. Therefore, the aim of this study was to determine whether the time to readmission in patients with mania treated with ECT was longer than in patients not treated with ECT and whether there were subgroups of patients that benefited more...
April 11, 2024: Acta Psychiatrica Scandinavica
https://read.qxmd.com/read/38602221/the-cognitive-effects-of-stopping-and-starting-antipsychotics-on-changes-in-cognitive-functioning
#18
JOURNAL ARTICLE
Brian G Collin
OBJECTIVES: The current study uses longitudinal data from the National Alzheimer's Coordinating Center (NACC) to assess the effects of antipsychotic medication use on changes in cognitive functioning among adults in the United States. METHODS: Linear mixed models were conducted that included study visits, days between visits, sex, age, education, and medical history (i.e. diabetes, seizures, traumatic brain injury, stroke, and Parkinson's disease). The Neuropsychiatric Inventory Questionnaire (NPI-Q) was used to create variables assessing changes in psychotic symptoms, manic symptoms, and agitation/disinhibition...
April 11, 2024: Aging & Mental Health
https://read.qxmd.com/read/38596629/aerobic-capacity-and-mitochondrial-function-in-bipolar-disorder-a-longitudinal-study-during-acute-phases-and-after-clinical-remission
#19
JOURNAL ARTICLE
Anna Giménez-Palomo, Mariona Guitart-Mampel, Gemma Roqué, Ester Sánchez, Roger Borràs, Ana Meseguer, Francesc Josep García-García, Esther Tobías, Laura Valls-Roca, Gerard Anmella, Marc Valentí, Luis Olivier, Oscar de Juan, Iñaki Ochandiano, Helena Andreu, Joaquim Radua, Norma Verdolini, Michael Berk, Eduard Vieta, Glòria Garrabou, Josep Roca, Xavier Alsina-Restoy, Isabella Pacchiarotti
BACKGROUND: Aerobic capacity has shown to predict physical and mental health-related quality of life in bipolar disorder (BD). However, the correlation between exercise respiratory capacity and mitochondrial function remains understudied. We aimed to assess longitudinally intra-individual differences in these factors during mood episodes and remission in BD. METHODS: This study included eight BD patients admitted to an acute psychiatric unit. Incremental cardiopulmonary exercise test (CPET) was conducted during acute episodes (T0), followed by constant work rate cycle ergometry (CWRCE) to evaluate endurance time, oxygen uptake at peak exercise (VO2peak ) and at the anaerobic threshold...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38595866/knee-buckling-as-an-atypical-adverse-effect-of-clozapine-a-case-report
#20
Javeria Sahib Din, Ernesto Navarro Garcia, Hiba Al-Rubaye, Carlos Julian
Clozapine has become a widely popular and effective medication in the treatment of refractory schizophrenia and refractory bipolar disorder. Although the use of clozapine proves to be an effective resort, it has to be closely monitored due to its narrow therapeutic range and multiple dangerous adverse effects. In rare cases, clozapine has been known to cause an antagonistic myoclonic jerk that leads to knee buckling. Here, we present the case of a 29-year-old female who is being treated for schizoaffective disorder, bipolar, manic type, who reported two instances of knee buckling associated with falls while taking clozapine...
March 2024: Curēus
keyword
keyword
20350
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.